(Q35751716)

10 August 2017

1 reference

title

Activated protein C in sepsis (English)

1 reference

10 August 2017

0 references

1 reference

Taylor FB

1

1 reference

10 August 2017

Kinasewitz G

series ordinal

2

1 reference

10 August 2017

publication date

1 May 2004

1 reference

Journal of Thrombosis and Haemostasis

10 August 2017

published in

1 reference

10 August 2017

volume

2

1 reference

10 August 2017

issue

5

1 reference

10 August 2017

page(s)

708-717

1 reference

Endothelial cell protein C receptor plays an important role in protein C activation in vivo

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00751.X

Activation mechanism of anticoagulant protein C in large blood vessels involving the endothelial cell protein C receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00751.X

Inflammation and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00751.X

Staging of the pathophysiologic responses of the primate microvasculature to Escherichia coli and endotoxin: examination of the elements of the compensated response and their links to the corresponding uncompensated lethal variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00751.X

Response of anticoagulant pathways in disseminated intravascular coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00751.X

Vessel injury and capillary leak

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00751.X

Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00751.X

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00751.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00751.X

Correlation between perioperative blood transfusion and prognosis of patients subjected to surgery for stage I lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00751.X

Drotrecogin alfa (activated) (recombinant human activated protein C) for the treatment of severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00751.X

Risk-benefit analysis for drotrecogin alfa (activated).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00751.X

Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00751.X

The clinical evaluation committee in a large multicenter phase 3 trial of drotrecogin alfa (activated) in patients with severe sepsis (PROWESS): Role, methodology, and results*

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00751.X

Pharmacokinetic-pharmacodynamic analysis of drotrecogin alfa (activated) in patients with severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00751.X

Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00751.X

Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00751.X

Specificity of coagulation factor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00751.X

The role of fibrin degradation products in neutrophil recruitment to the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00751.X

Gabexate mesilate, a synthetic protease inhibitor, attenuates endotoxin-induced pulmonary vascular injury by inhibiting tumor necrosis factor production by monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00751.X

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00751.X

10.1111/J.1538-7836.2004.00751.X

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference